A previous study has demonstrated that the methylations on the EGFR extracellular domain mediated by PRMT1 enhance receptor function in colorectal cancer cells, affecting the EGF-EGFR binding affinity to promote tumorigenesis 57. The gene discussed is EGFR; the disease is colorectal cancer.